NEW YORK - Lucid Diagnostics Inc. (NASDAQ:LUCD) announced Tuesday results from what it describes as the largest real-world experience of non-endoscopic esophageal precancer detection using its ...
A ransomware attack at Motility Software Solutions, a provider of dealer management software (DMS), has exposed the sensitive data of 766,000 customers. Motility (formerly known as Systems 2000/Sys2K) ...
Proteomics International has launched PromarkerEso at the ISDE World Congress in Brisbane (18–20 September). PromarkerEso is a world-first protein biomarker-based blood diagnostic that can rule out ...
Background: Gastroesophageal reflux disease has a prevalence of 12% in the Brazilian population. Its treatment includes hygienic-dietary changes, use of medications and, in selected cases, surgery ...
FULLERTON, Calif. (KABC) -- The latest findings reveal esophageal cancer rates are up across the board. Many factors can raise your risk, including your line of work. A recently FDA-approved, ...
This year, more than 22,000 Americans face a chilling diagnosis — esophageal cancer. Men are three to four times more likely to develop it. The odds? Less than a 20% chance of surviving five years.
(WISH) — A new non-invasive test called EsoGuard offers hope for early detection of esophageal cancer, a disease affecting over 22,000 Americans each year. Esophageal cancer has a grim prognosis, with ...
A new, non-invasive test called ESOGuard is giving patients a better chance at surviving one of the deadliest cancers in the country. More than 22,0000 Americans are expected to be diagnosed with ...
Rachel Feltman: For Scientific American’s Science Quickly, I’m Rachel Feltman. The World Health Organization estimates that infertility impacts one in six adults globally. But when it comes to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback